Prognoses of T4 breast cancer subsets

Annals of Surgical Oncology

Volumn 9, Issue 4, 2002, Pages 340-345

  El Tamer, Mahmoud ^a   Hussain, Sabir ^b   Weedon, Jeremy ^c   Chalchal, Haji ^f   Chakrabarti, Ashis ^d   Sohn, Chul ^e   Braverman, Albert S ^d  

^a New York Presbyterian Hospital Columbia University Medical Center   (United States)

^b Horizon Health Network   (Canada)

^c Box 55 ^*  (United States)

^d Department of Medicine   (United States)

^e SUNY DOWNSTATE MEDICAL CENTER   (United States)

^f Allan Blair Cancer Centre   (Canada)

Author keywords

Breast cancer; Inflammatory carcinoma; Prognosis; T4 breast tumor

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE; PACLITAXEL; TAMOXIFEN;

ARTICLE; BREAST CANCER; BREAST INFLAMMATORY CARCINOMA; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MASTECTOMY; METASTASIS; PROGNOSIS; SKIN NODULE; TREATMENT OUTCOME;

BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INCIDENCE; INFLAMMATION; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM STAGING; PREVALENCE; PROGNOSIS; TIME FACTORS;

EID: 0036252161     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1245/aso.2002.9.4.340     Document Type: Article

References (25)

1. Inflammatory carcinoma of the breast
2. Cell kinetics and hormonal receptor status in inflammatory breast carcinoma
3. Inflammatory carcinoma of the breast: A correlation of clinical, radiologic and pathologic findings
4. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas
5. Prognosis in inoperable stage III carcinoma of the Breast
6. Long-term survival and prognostic factors in patients with regional breast cancer (skin, muscle and/or chest wall involvement)
7. Multimodal therapy for locally advanced breast cancer
8. Inflammatory carcinoma of the breast
9. Invasive mammary carcinoma
10. Inflammatory carcinoma of the breast
11. Inflammatory carcinoma of the breast
12. Secondary inflammatory breast cancer
13. The influence of delay on the natural history and prognosis of breast cancer
14. Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral superclavicular metastases
15. Patient compliance with aggressive multimodal therapy in locally advanced breast cancer
16. Screening for recurrent breast cancer
17. Bone scintigraphy in benign and malignant tumors
18. Bone metastases and bone pain in breast cancer
19. The influence of bone pain on the results of bone scan
20. Sequential bone scans and chest radiographs in the post-operative management of early breast cancer
21. Evaluation of bone scan as a screening work-up in primary and local-regional recurrence of breast cancer
22. Bone scintigrams: Their clinical usefulness in patients with breast carcinoma
23. Malignant bone disease